Summary
The ubiquitin-proteasome system plays a pivotal role in breast tumorigenesis by controlling transcription factors, thus promoting cell cycle growth, and degradation of tumor suppressor proteins. However, breast cancer patients have failed to benefit from proteasome inhibitor treatment partially due to proteasome heterogeneity, which is poorly understood in malignant breast neoplasm. Chemical crosslinking is an increasingly important tool for mapping protein three-dimensional structures and proteinprotein interactions. In the present study, two cross-linkers, bis (sulfosuccinimidyl) suberate (BS3) and its water-insoluble analog disuccinimidyl suberate (DSS), were used to map the subunit-subunit interactions in 20S proteasome core particle (CP) from MDA-MB-231 cells. Different types of gel electrophoresis technologies were used. In combination with chemical cross-linking and mass spectrometry, we applied these gel electrophoresis technologies to the study of the noncovalent interactions among 20S proteasome subunits. Firstly, the CP subunit isoforms were profiled. Subsequently, using native/SDSPAGE, it was observed that 0.5 mmol/L BS3 was a relatively optimal cross-linking concentration for CP subunit-subunit interaction study. 2-DE analysis of the cross-linked CP revealed that α1 might preinteract with α2, and α3 might pre-interact with α4. Moreover, there were different subtypes of α1α2 and α3α4 due to proteasome heterogeneity. There was no significant difference in cross-linking pattern for CP subunits between BS3 and DSS. Taken together, the gel-based characterization in combination with chemical cross-linking could serve as a tool for the study of subunit interactions within a multi-subunit protein complex. The heterogeneity of 20S proteasome subunit observed in breast cancer cells may provide some key information for proteasome inhibition strategy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Baumeister W, Walz J, Zuhl F, et al. The proteasome: paradigm of a self-compartmentalizing protease. Cell, 1998,92(3):367–380
Lloyd RV, Erickson LA, Jin L, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol, 1999,154(2):313–323
Chiarle R, Pagano M, Inghirami G. The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast Cancer Res, 2001,3(2):91–94
Lonard DM, Nawaz Z, Smith CL, et al. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptoralpha transactivation. Mol Cell, 2000,5(6):939–948
Citri A, Alroy I, Lavi S, et al. Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy. EMBO J, 2002,21(10):2407–2417
Gu ZC, Enenkel C. Proteasome assembly. Cell Mol life Sci, 2014,71(24):4729–4745
Kunjappu MJ, Hochstrasser M. Assembly of the 20S proteasome. BBA-Mol Cell Res, 2014,1843(1):2–12
Dahlmann B, Ruppert T, Kloetzel PM, et al. Subtypes of 20S proteasomes from skeletal muscle. Biochimie, 2001,83(3-4):295–299
Dahlmann B, Ruppert T, Kuehn L, et al. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol, 2000,303(5):643–653
Busse A, Kraus M, Na IK, et al. Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits. Cancer, 2008,112(3):659–670
Chen D, Frezza M, Schmitt S, et al. Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. Curr Cancer Drug Targets, 2011,11(3):239–253
Sato K, Rajendra E, Ohta T. The UPS: a promising target for breast cancer treatment. BMC Biochem, 2008,9 Suppl 1:S2
Drews O, Wildgruber R, Zong C, et al. Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteomics, 2007,6(11):2021–2031
Zong C, Young GW, Wang Y, et al. Two-dimensional electrophoresis-based characterization of posttranslational modifications of mammalian 20S proteasome complexes. Proteomics, 2008,8(23-24):5025–5037
Sinz A. Chemical cross-linking and mass spectrometry to map three-dimensional protein structures and proteinprotein interactions. Mass Spectrom Rev, 2006,25(4): 663–682
Vasilescu J, Figeys D. Mapping protein-protein interactions by mass spectrometry. Curr Opin Biotechnol, 2006,17(4):394–399
Wang X, Zhao Z, Luo Y, et al. Gel-based proteomics analysis of the heterogeneity of 20S proteasomes from four human pancreatic cancer cell lines. Proteomics Clin Appl, 2011,5(9-10):484–492
Hayter JR, Doherty MK, Whitehead C, et al. The subunit structure and dynamics of the 20S proteasome in chicken skeletal muscle. Mol Cell Proteomics, 2005,4(9):1370–1381
Chen G, Luo Y, Wang X, et al. A relatively simple and economical protocol for proteomic analyses of human 20S proteasome: Compatible with both scaled-up and scaled-down purifications. Electrophoresis, 2009,30(14): 2422–2430
Elsasser S, Schmidt M, Finley D. Characterization of the proteasome using native gel electrophoresis. Methods Enzymol, 2005,398:353–363
Drews O, Zong C, Ping P. Exploring proteasome complexes by proteomic approaches. Proteomics, 2007,7(7):1047–1058
Ducoux-Petit M, Uttenweiler-Joseph S, Brichory F, et al. Scaled-down purification protocol to access proteomic analysis of 20S proteasome from human tissue samples: comparison of normal and tumor colorectal cells. J Proteome Res, 2008,7(7):2852–2859
Bousquet-Dubouch MP, Uttenweiler-Joseph S, Ducoux-Petit M, et al. Purification and proteomic analysis of 20S proteasomes from human cells. Methods Mol Biol, 2008,432:301–320
Gronborg M, Kristiansen TZ, Stensballe A, et al. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics, 2002,1(7):517–527
Madler S, Bich C, Touboul D, et al. Chemical crosslinking with NHS esters: a systematic study on amino acid reactivities. J Mass Spectrometrym, 2009,44(5):694–706
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by the National Natural Science Foundation of China (No. 81202095), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120142120053) and the Hubei Provincial Natural Science Foundation of China (No. 2013CFB134).
Rights and permissions
About this article
Cite this article
Song, H., Xiong, H., Che, J. et al. Gel-based chemical cross-linking analysis of 20S proteasome subunit-subunit interactions in breast cancer. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 36, 564–570 (2016). https://doi.org/10.1007/s11596-016-1626-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-016-1626-3